Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families

Neurobiology of Disease

Volumn 5, Issue 1, 1998, Pages 37-45

  Etcheberrigaray, René ^a   Hirashima, Naohide ^b,f   Nee, Linda ^b   Prince, José ^b   Govoni, Stefano ^d   Racchi, Marco ^e   Tanzi, Rudolph E ^c   Alkon, Daniel L ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PAVIA   (Italy)

^e Sacred Heart Hospital FBF   (Italy)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alzheimer's disease; Calcium; Fibroblast

Indexed keywords

BOMBESIN; BRADYKININ; CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; POTASSIUM CHANNEL; POTASSIUM ION; TETRYLAMMONIUM;

ALZHEIMER DISEASE; ARTICLE; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; FAMILIAL DISEASE; FIBROBLAST; HIGH RISK POPULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0032127927     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1998.0176     Document Type: Article

References (29)

1. Baker A. C., Ko L.-W., Blass J. P. Systemic manifestations of Alzheimer's disease. Age. 11:1988;60-65.
2. i. Neurobiol. Aging. 13:1991;33-38.
3. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G. E., Alkon D. L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8209-8213.
4. Etcheberrigaray R., Gibson G. E., Alkon D. L. Molecular mechanism of memory and the pathophysiology of Alzheimer's disease. Ann. N. Y. Acad. Sci. 747:1994;245-255.
5. Etcheberrigaray R., Alkon D. L. Potassium channels and calcium release: Pathophysiological and diagnostic implications for Alzheimer's disease. Molecular Models of Dementia. 1997;Humana Press, Clifton. p. 239-252.
6. Gibson G. E., Martins R., Blass J., Gandy S. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sci. 59:1996a;477-489.
7. Gibson G. E., Zhang H., Toral-Barza L., Szolosi S., Tofel-Grehl B. Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. Biochim. Biophys. Acta. 1316:1996b;71-77.
8. Gibson G. E., Vestling M., Zhang H., Szolosi S., Alkon D., Lannfelt L., Gandy S., Cowburn R. F. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol. Aging. 18:1997;573-580.
9. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti G., Bianchetti A., Trabucchi M. Cytosol protein kinase C down regulation in fibroblasts from Alzheimer's disease patients. Neurology. 43:1993;2581-2586.
10. Hardy J. Molecular genetics of Alzheimer's disease. Acta Neurol. Scand. 165:1996;13-17.
11. Hirashima N., Etcheberrigaray R., Bergamaschi S., Racchi M., Battaini F., Binetti G., Govoni S., Alkon D. L. Calcium responses in human fibroblasts: A diagnostic molecular profile for Alzheimer's disease. Neurobiol. Aging. 17:1996;549-555.
12. Huang H.-M., Lin T.-A., Sun G. Y., Gibson G. E. Increased inositol 1,4,5-triphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 64:1995;761-766.
13. Huang H.-M., Martins R., Gandy S., Etcheberrigaray R., Ito E., Alkon D. L., Blass J., Gibson G. Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 747:1994;225-243.
14. Huang H.-M., Toral-Barza L., Thaler H., Tofel-Grehl B., Gibson G. E. Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged and Alzheimer donors. Neurobiol. Aging. 12:1991;469-473.
15. 2+. Proc. Natl. Acad. Sci. USA. 91:1994;534-538.
16. Kim C. S., Han Y.-F., Etcheberrigaray R., Nelson T. J., Olds J. L., Yoshioka T., Alkon D. L. Alzheimer and β-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20. Proc. Natl. Acad. Sci. USA. 92:1995;3060-3064.
17. Matsuyama S. S., Yamaguchi D. T., Vegara J., Jarvik L. F. Tetraethylammonium-induced calcium concentration changes in skin fibroblasts from patients with Alzheimer disease. Dementia. 6:1995;241-244.
18. McCoy K. R., Mullins R. D., Newcomb T. G., Ng G. M., Pavlinkova G., Polinsky R. J., Nee L. E., Sisken J. E. Serum- and bradykinin-induced calcium transients in familial Alzheimer's fibroblasts. Neurobiol. Aging. 14:1993;447-455.
19. Motulsky H. Intuitive Biostatistics. 1995;Oxford Univ. Press, New York.
20. Catalog of Cell Lines. 1994;U.S. Department of Health and Human Services Public Health Service National Institutes of Health, Bethesda.
21. Nee L. E., Polinsky R. J., Eldridge R., Weingartner H., Smallberg S., Ebert M. A family with histologically confirmed Alzheimer's disease. Arch. Neurol. 40:1983;203-208.
22. Peterson C., Ratan R. R., Shelanski M. L., Goldman J. E. Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium. Neurobiol. Aging. 9:1988;261-266.
23. Remington R. D., Schork M. A. Statistics with Applications to the Biological and Health Sciences. 1985;Pentice Hall, Englewood Cliffs.
24. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
25. Scott R. B. Extraneuronal manifestations of Alzheimer's disease. J. Am. Geriatr. Soc. 41:1993;268-276.
26. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainiero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
27. Tanzi R. E., Kovacs D. M., Kim T.-W., Moir R. D., Guenette S. Y., Wasco W. The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3:1996;159-168.
28. Tatebayashi Y., Masatoshi T., Kashiwagi Y., Masayasu O., Kurumadani T., Sekiyama A., Kanayama G., Hariguchi S., Nishimura T. Cell-cycle dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia. 6:1995;9-16.
29. Vestling M., Adem A., Lannfelt L., Cowburn R. F. Protein kinase C levels and activity in cultured skin fibroblasts from affected and nonaffected of the Swedish family with the amyloid precursor protein 670/671 mutation. Soc. Neurosci. Abstr. 25:1995;744.